The Institutional Biosafety Committee (IBC Institutional Biosafety Committee The IBC is an instituti...) is an institutional committee created under the NIH National Institutes of Health Guidelines to review research involving recombinant DNA and synthetic nucleic acid research. The IBC also reviews all research involving biohazardous materials and has overall oversight and responsibility for the Biosafety program at BU and BMC. The IBC carries out these functions pursuant to requirements set forth by federal, state, and local agencies, as well as BU.
Important Announcements
Nondiscrimination Policy Update
Boston Medical Center Health System complies with applicable Federal civil rights laws and does not discriminate on the basis of age, race, color, national origin (including limited English proficiency and primary language), religion, culture, physical or mental disabilities, socioeconomic status, sex, sexual orientation and gender identity and/or expression. BMCHS provides free aids and services to people with disabilities and free language services to people whose primary language is not English.
To read our full Nondiscrimination Statement, click here.
Popular Searches